David Rubin to Nasopharyngitis
This is a "connection" page, showing publications David Rubin has written about Nasopharyngitis.
Connection Strength
0.240
-
Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sclerosis. Inflamm Bowel Dis. 2026 May 01; 32(5):954-962.
Score: 0.240